Zentek ( (TSE:ZEN) ) has shared an announcement.
Zentek Ltd. has successfully completed shelf-life efficacy testing for its ZenGUARD™ Enhanced Air Filters, demonstrating that the product maintains its viral filtration efficiency over a 20-month period. This achievement is crucial for the commercialization of the filters as a Class I medical device, ensuring compliance with medical device regulations and confirming the product’s reliability and safety for stakeholders.
More about Zentek
Zentek Ltd. is an intellectual property technology development and commercialization company. It focuses on developing innovative products, such as the ZenGUARD™ Enhanced Air Filters, which are intended for use as medical devices, emphasizing consistent performance and safety.
YTD Price Performance: -6.12%
Average Trading Volume: 47,256
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $93.93M
See more insights into ZEN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com